RT Journal Article
SR Electronic
T1 Identifying Importation and Asymptomatic Spreaders of Multi-drug Resistant Organisms in Hospital Settings
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.14.24310393
DO 10.1101/2024.07.14.24310393
A1 Cui, Jiaming
A1 Heavey, Jack
A1 Klein, Eili
A1 Madden, Gregory R.
A1 Vullikanti, Anil
A1 Prakash, B. Aditya
YR 2024
UL http://medrxiv.org/content/early/2024/07/15/2024.07.14.24310393.abstract
AB Healthcare-associated infections (HAIs) due to multi-drug resistant organisms (MDROs) are a significant burden to the healthcare system. Patients are sometimes already infected at the time of admission to the hospital (referred to as “importation”), and additional patients might get infected in the hospital through transmission (“nosocomial infection”). Since many of these importation and nosocomial infection cases may present no symptoms (i.e., “asymptomatic”), rapidly identifying them is difficult since testing is limited and incurs significant delays. Although there has been a lot of work on examining the utility of both mathematical models of transmission and machine learning for identifying patients at risk of MDRO infections in recent years, these methods have limited performance and suffer from different drawbacks: Transmission modeling-based methods do not make full use of rich data contained in electronic health records (EHR), while machine learning-based methods typically lack information about mechanistic processes. In this work, we propose NeurABM, a new framework which integrates both neural networks and agent-based models (ABM) to combine the advantages of both modeling-based and machine learning-based methods. NeurABM simultaneously learns a neural network model for patient-level prediction of importation, as well as the ABM model which is used for identifying infections. Our results demonstrate that NeurABM identifies importation and nosocomial infection cases more accurately than existing methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the NSF (Expeditions CCF-1918770, CAREER IIS-2028586, RAPID IIS-2027862, Medium IIS-1955883, Medium IIS-2106961, PIPP CCF-2200269), Centers for Disease Control and Prevention Modeling Infectious Diseases In Healthcare program (5U01CK000589), National Institutes of Health (K23AI163368 to G.R.M.) and National Center for Advancing Translational Science (UL1TR003015, KL2TR003016 to G.R.M.), faculty research award from Facebook and funds/computing resources from Georgia Tech.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work is a retrospective observational study and follows the STROBE statement checklist. This study received approval from the University of Virginia Institutional Review Board (#22410).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe outputs of our model are available on GitHub via link: https://github.com/AdityaLab/NEURABM. The electronic health record (EHR) data used in developing the models is not available since it is highly sensitive, and we do not have permission to release it. However, we provide the code, a demo, and a synthetic dataset on GitHub.